The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Genetic epidemiology and Mendelian randomization for informing disease therapeutics: Conceptual and methodological challenges
Open accessPublished version of a preprint
Abstract
The past decade has been proclaimed as a hugely successful era of gene discovery through the high yields of many genome-wide association studies (GWAS).However, much of the perceived benefit of such discoveries lies in the promise that the identification of genes that influence disease would directly translate into the identification of potential therapeutic targets, but this has yet to be realized at a level reflecting expectation.One reason for this, we suggest, is that GWAS, to date, have generally not focused on phenotypes that directly relate to the progression of disease and thus speak to disease treatment.A valuable proposed outcome of the GWAS era is the identification of novel therapeutic targets [1-4].As of 3 April 2017, the GWAS Catalog contained 2,854 publications and 33,674 unique SNP-trait associations [5].The large majority of these studies investigate genetic variation related to the presence (or occurrence) of disease.Such variants, though they may be informative for the prevention of disease, have unclear utility in informing disease treatment.If variants implicate etiological mechanisms of import for disease onset but sometimes of little relevance to disease progression, then the use of case/control GWAS as evidence to inform disease treatment-related drug discovery could be misleading.As an obvious example, consider GWAS of lung cancer.The lead variants identified in such GWAS tag a locus related to the heaviness of cigarette smoking [6], supporting the overwhelming evidence that smoking causes lung cancer.However, the cessation of smoking is hardly an efficacious treatment strategy after the onset of disease, although not smoking is a highly effective means of very substantially reducing the risk of developing lung cancer in the first place.Examples of factors causing both disease incidence and disease progression exist-for example, low-density lipoprotein (LDL) cholesterol levels clearly influence the risk of initial coronary events, and lowering LDL cholesterol reduces the risk of subsequent events.However, it is not necessarily the case that risk factors will influence both disease onset and disease progression-for example, a recent GWAS of Crohn disease observed independent genetic variants for the risk of onset and progression [7] and reported a negative genetic correlation (estimated through linkage disequilibrium [LD]
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, many such papers simply report MR estimates obtained from applying open-access software to open-access data and in these cases the analyses have, in essence, already been conducted by automated tools — an observation detailed in a recent preprint article.182”
From Mendelian randomization (2022) · cites this paper as [182]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
Davey Smith, G., & Hemani, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu328 · Cited by 4,677
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N., & Davey Smith, G. (2008) · Statistics in Medicine · doi:10.1002/sim.3034 · Cited by 4,618
Pierce, B. L., & Burgess, S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt084 · Cited by 1,389
Collider scope: when selection bias can substantially influence observed associations
Munafò, M. R., Tilling, K., Taylor, A. E., Evans, D. M., & Davey Smith, G. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyx206 · Cited by 813
Self-citationVariation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
Ference, B. A., Robinson, J. G., Brook, R. D., Catapano, A. L., Chapman, M. J., Neff, D. R., Voros, S., Giugliano, R. P., Davey Smith, G., Fazio, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604304 · Cited by 743
Holmes, M. V., Dale, C. E., Zuccolo, L., Silverwood, R. J., Guo, Y., Ye, Z., Prieto-Merino, D., Dehghan, A., Trompet, S., Wong, A., et al. (2014) · BMJ · doi:10.1136/bmj.g4164 · Cited by 669
C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC) (2011) · BMJ · doi:10.1136/bmj.d548 · Cited by 642
Mendelian randomization studies: a review of the approaches used and the quality of reporting
Boef, A. G. C., Dekkers, O. M., & le Cessie, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv071 · Cited by 610
Role of Folate in Colon Cancer Development and Progression
Kim, Y.-I. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.11.3731s · Cited by 386
Flagged first, then by citations
1 of the 38 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- MR Munafo, Collider Scope: How selection bias can induce spurious associations, Int J Epidemiol
- F Balazard, 2017, Disease as collider: a new case-only method to discover environmental factors in complex diseases with genetic risk estimation, BioRxiv
Cited by
Sorted by citations
Items 201–271 of 271
So, H., Chau, C. K., & Zhao, K. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/170241 · Cited by 2
Adiposity and Cardiometabolic Outcomes
Wade, K. H., & Smith, G. D. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.3778 · Cited by 2
Leveraging human genetics to inform intervention strategies for multiple sclerosis
Goris, A., & Dubois, B. (2019) · Neurology · doi:10.1212/wnl.0000000000007298 · Cited by 2
Wang, W., & Xia, H. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149238 · Cited by 1
Gut metabolites and functional recovery after ischemic stroke: a genetic perspective
Wu, W., Zhu, L., Zhang, J., Li, X., Yu, D., Wang, Y., Su, Y., Wei, X., Ma, H., Song, W., et al. (2025) · Mammalian Genome · doi:10.1007/s00335-025-10120-4 · Cited by 1
Niu, H., Xia, L., Zhang, X., Lin, C., Ge, Y., Chen, Y., Sun, F., Jiang, F., & Wu, C. (2025) · Gynecologic and Obstetric Investigation · doi:10.1159/000546487 · Cited by 2
Smart, S. E., Fenner, E., Rhys, H., Wells, A., Fender, K., Bresner, C., Trauzzi, G., Willcocks, I. R., Legge, S. E., Pardiñas, A. F., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340584 · Cited by 1
Sobczyk, M. K., & Gaunt, T. R. (2026) · Scientific Reports · doi:10.1038/s41598-026-41818-3 · Cited by 2
Challenges and future directions for Mendelian randomization
Sanderson, E. C. M., Levin, M. G., Walker, V. M., Yuan, S., Badini, I., Dolce, J., Mahida, K. J., Nho, J.-W., Pingault, J., Damrauer, S. M., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02546-6 · Cited by 2
Zhang, S., Ji, J., Zhang, Z., Cui, Z., & Su, M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1333528 · Cited by 1
Effects of immune cells on ischemic stroke and the mediating roles of metabolites
Hu, H., Zhou, M., Zhao, Y., Mao, J., & Yang, X. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1405108 · Cited by 1
Grant, A. J. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15114 · Cited by 1
A Note on Posttreatment Selection in Studying Racial Discrimination in PolicingPreprint
Zhao, Q., Keele, L. J., Small, D. S., & Joffe, M. M. (2020) · arXiv (Cornell University) · doi:10.17863/cam.73832 · Cited by 1
Hannigan, L. J., & Havdahl, A. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13416 · Cited by 1
Genetic control of fetal placental genomics contributes to development of health and diseasePreprint
Bhattacharya, A., Freedman, A. N., Avula, V. R., Harris, R., Liu, W., Pan, C., Lusis, A. J., Joseph, R. M., Smeester, L., Hartwell, H. J., et al. (2021) · medRxiv · doi:10.1101/2021.04.12.21255170 · Cited by 1
Wang, F., Mi, J., Bai, X., Ruan, G., Zhang, Y., & Yu, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1751879/v2 · Cited by 1
Gill, D., Zagkos, L., Gill, R., Benzing, T. R., Jordan, J., Birkenfeld, A. L., Burgess, S., & Zahn, G. (2023) · medRxiv · doi:10.1101/2023.08.29.23294760 · Cited by 1
Yan, D., Hu, B., Darst, B. F., Mukherjee, S., Kunkle, B. W., Deming, Y. K., Dumitrescu, L. C., Wang, Y., Naj, A. C., Kuzma, A. B., et al. (2023) · eLife · doi:10.7554/elife.91360.1 · Cited by 1
Faber, B. G., Frysz, M., Zheng, J., Lin, H., Flynn, K. A., Ebsim, R., Saunders, F. R., Beynon, R. A., Gregory, J. S., Aspden, R. M., et al. (2024) · medRxiv · doi:10.1101/2024.01.26.24301811 · Cited by 1
A Mendelian randomization study identifies proteins involved in neurodegenerative diseasesPreprint
Belbasis, L., Morris, S., van Duijn, C. M., Bennett, D., & Walters, R. G. (2024) · medRxiv · doi:10.1101/2024.02.24.24303314 · Cited by 1
Flipping the odds of drug development success through human genomicsPreprint
Hingorani, A. D., Kuan, V., Finan, C., Krüger, F. A., Gaulton, A., Chopade, S., Sofat, R., MacAllister, R. J., Overington, J. P., Hemingway, H., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/170142
Body mass index and carpal tunnel syndrome: a Mendelian randomization studyPreprint
Daghlas, I., & Varady, N. H. (2019) · medRxiv · doi:10.1101/19011536
Ong, J. (2019) · The University of Queensland · doi:10.14264/uql.2019.880
A category theoretical argument for causal inferencePreprint
Tuyéras, R. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2004.09999
Zheng, J., Zhang, Y., Zhao, H., Liu, Y., Baird, D. A., Karim, M. A., Ghoussaini, M., Schwartzentruber, J., Dunham, I., Elsworth, B., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4053476
Wang, F., Mi, J., Bai, X., Ruan, G., Zhang, Y., & Yu, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1751879/v1
Obesity and sex- and age-specific income – evidence from the HUNT studyPreprint
Edwards, C. H., Bjørngaard, J. H., & Kinge, J. M. (2022) · Research Square · doi:10.21203/rs.3.rs-2275770/v1
Review: Mendelian randomization as a tool to inform drug development using human genetics — R1/PR7
Daghlas, I., & Gill, D. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.5.pr7
Review: Mendelian randomization as a tool to inform drug development using human genetics — R1/PR8
Daghlas, I., & Gill, D. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.5.pr8
Gill, D. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.5.pr6
Daghlas, I., & Gill, D. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.5.pr4
Daghlas, I., & Gill, D. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.5.pr9
Daghlas, I., & Gill, D. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.5.pr10
Decision: Mendelian randomization as a tool to inform drug development using human genetics — R0/PR5
Daghlas, I., & Gill, D. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.5.pr5
Review: Mendelian randomization as a tool to inform drug development using human genetics — R0/PR2
Daghlas, I., & Gill, D. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.5.pr2
Review: Mendelian randomization as a tool to inform drug development using human genetics — R0/PR3
Daghlas, I., & Gill, D. (2022) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.5.pr3
Gill, D. (2022) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.5.pr1
Tian, H., Tom, B. D. M., & Burgess, S. (2023) · medRxiv · doi:10.1101/2023.10.28.23297706
Zhang, M., Duan, L., & Feng, Y. (2024) · Medicine · doi:10.1097/md.0000000000037753
Huang, K., Wang, X., Lin, B., Liu, Y., Ren, H., & Guo, Q. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4800409
Zhang, B., Liang, C., & Guo, S. (2024) · Research Square · doi:10.21203/rs.3.rs-4828099/v1
Is CD27 Ligand the Cause of the Increased Incidence of Epilepsy? A mendelian randomization studyPreprint
Zhang, B., Liang, C., & Guo, S. (2024) · Research Square · doi:10.21203/rs.3.rs-4889861/v1
Xu, Z., Liu, Y., Xu, J., & Cheng, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4907221/v1
Luo, L., Yang, Y., He, J., Bao, Y., Jiang, F., Wu, C., & Zhang, T. (2025) · Lymphatic Research and Biology · doi:10.1089/lrb.2024.0018
Xu, Z., Zeng, X., Guo, H., Zhan, T., Yide, L., Chou, S., & Luo, L. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5409115
Cui, W., Wu, T.-T., Shi, K., Wang, X., Chen, S., Cao, M., Xu, A., Chong, Y., Zhang, X., & Wang, Q. (2025) · Medicine · doi:10.1097/md.0000000000044473
Li, Y., Yao, J., Wang, M., Hu, J., Yuan, Y., Qu, Y., Zhang, W., Yu, Y., Lu, X., Liang, C., et al. (2025) · Gastroenterology Research and Practice · doi:10.1155/grp/7800569
Wan, F. J., Shen, J., & Tang, J. (2025) · Medicine · doi:10.1097/md.0000000000045444
Junior, H. P. D. O. S., Bhattacharya, A., Joseph, R. M., Smeester, L., Kuban, K., Marsit, C. J., O’Shea, T. M., & Fry, R. C. (2020) · Figshare · doi:10.6084/m9.figshare.13467637
Escala-Garcia, M., Morra, A., Canisius, S., Chang-Claude, J., Kar, S., Zheng, W., Bojesen, S. E., Easton, D., Pharoah, P. D. P., & Schmidt, M. K. (2020) · Figshare · doi:10.6084/m9.figshare.13245820
Yang, Q., Magnus, M. C., Kilpi, F., Santorelli, G., Soares, A. G., West, J., Magnus, P. M., Wright, J., Håberg, S. E., Sanderson, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21078739
Self-citationEscala-Garcia, M., Morra, A., Canisius, S., Chang-Claude, J., Kar, S., Zheng, W., Bojesen, S. E., Easton, D., Pharoah, P. D. P., & Schmidt, M. K. (2020) · Figshare · doi:10.6084/m9.figshare.13245823
Tian, H., Tom, B. D. M., & Burgess, S. (2024) · Figshare · doi:10.6084/m9.figshare.26679518
Junior, H. P. D. O. S., Bhattacharya, A., Joseph, R. M., Smeester, L., Kuban, K., Marsit, C. J., O’Shea, T. M., & Fry, R. C. (2020) · Figshare · doi:10.6084/m9.figshare.13467641
The causal relationships between childhood-onset asthma and major mental disorders: an MR study
He, Z., Chen, B., Xue, M., & Deng, Q. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02200-6
Adhikari, N., Lunetta, K. L., GAGNON, D. R., & Peloso, G. M. (2026) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2026.100592
Ding, Y., Liu, H., Jiang, L., Yang, Q., Wang, S., Lin, H., Li, M., Zhao, Z., Wang, T., Xu, M., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06747-w
Xue, H., Hao, X., Liu, D., Li, Y., & Yu, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1840631
Bate, T., Dong, M., Liu, Y., Seviiri, M., Brown, M. C., Atkins, J. R., Smith-Byrne, K., Hung, R., Law, M. H., Iles, M. M., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9656350/v1
Connecting diet and disease: Using Mendelian randomisation to bridge the gapPreprint
Deslandes, B., Corbin, L. J., Goudswaard, L. J., Sandu, M., Lee, M. A., Beynon, R. A., McGeagh, L., Smith, G. D., Sattar, N. A., Lean, M. E. J., et al. (2026) · medRxiv · doi:10.64898/2026.09.02.26362020
FAIRsharing record for: Genome-Wide Association Studies Catalog
FAIRsharing Team, Lister, A., & Parkinson, H. (2018) · FAIRsharing.org · doi:10.25504/fairsharing.blumrx
Metadata
- Authors
- Paternoster, L., Tilling, K., & Davey Smith, G.
- Affiliations
- University of Bristol (GB)
- Corresponding author
- Paternoster, Lavinia
- Tilling, Kate
- Venue
- PLOS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-10-05
- Volume
- 13
- Issue
- 10
- Pages
- e1006944
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC5628782
- OpenAlex
- W2951286101
- Cited by
- 271
- References
- 38
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 37 · 2023: 37 · 2022: 38 · 2021: 47 · 2020: 36 · 2019: 23 · 2018: 21 · 2017: 6
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Explore Bristol Research (submittedVersion, cc-by)
- Funders
- Medical Research Council (MC_UU_12013, MCUU12013/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and phenotypic traits in livestock
- Keywords
- drug target identification, disease progression, genetic epidemiology, Mendelian randomization, genome-wide association study, drug discovery, genetic correlation, Crohn's disease, LDL cholesterol, smoking and lung cancer
- MeSH terms
- Coronary Disease, Humans, Phenotype, Risk Factors, Disease Progression, Genetic Predisposition to Disease, Genetic Diseases, Inborn, Genome-Wide Association Study, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
